JP2024522783A5 - - Google Patents
Info
- Publication number
- JP2024522783A5 JP2024522783A5 JP2023577845A JP2023577845A JP2024522783A5 JP 2024522783 A5 JP2024522783 A5 JP 2024522783A5 JP 2023577845 A JP2023577845 A JP 2023577845A JP 2023577845 A JP2023577845 A JP 2023577845A JP 2024522783 A5 JP2024522783 A5 JP 2024522783A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- prodrug
- pharmaceutical product
- alkyl
- product according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163212468P | 2021-06-18 | 2021-06-18 | |
| US63/212,468 | 2021-06-18 | ||
| PCT/US2022/033654 WO2022266237A1 (en) | 2021-06-18 | 2022-06-15 | Prodrugs of deoxynucleosides for treatment of mitochondrial diseases caused by unbalanced nucleotide pools |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522783A JP2024522783A (ja) | 2024-06-21 |
| JP2024522783A5 true JP2024522783A5 (https=) | 2025-06-24 |
Family
ID=84526701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577845A Pending JP2024522783A (ja) | 2021-06-18 | 2022-06-15 | 不均衡なヌクレオチドプールによって引き起こされたミトコンドリア疾患を治療するためのデオキシヌクレオシドのプロドラッグ |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20230000890A1 (https=) |
| EP (1) | EP4355336A4 (https=) |
| JP (1) | JP2024522783A (https=) |
| CN (1) | CN117500510A (https=) |
| AU (1) | AU2022291783A1 (https=) |
| CA (1) | CA3222484A1 (https=) |
| IL (1) | IL309421A (https=) |
| MX (1) | MX2023014944A (https=) |
| WO (1) | WO2022266237A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022204555A1 (en) * | 2021-03-26 | 2022-09-29 | Zogenix Mds, Inc. | Aqueous solutions containing purines and pyrimidines and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10292996B2 (en) * | 2015-03-26 | 2019-05-21 | The Trustees Of Columbia University In The City Of New York | Deoxyribonucleoside monophospate bypass therapy for mitochondrial DNA depletion syndrome |
| LT3505174T (lt) * | 2015-06-17 | 2020-09-10 | The Trustees Of Columbia University In The City Of New York | Deoksinukleozidų terapija, skirta gydyti ligas, kurias sukelia nesubalansuoti nukleotidų kiekiai, įskaitant mitochondrinės dnr išsekimo sindromus |
| CA3005444A1 (en) * | 2015-11-16 | 2017-05-26 | Ichorion Therapeutics, Inc. | Nucleic acid prodrugs |
| CA3096264A1 (en) * | 2018-04-12 | 2019-10-17 | Modis Therapeutics Inc. | Prodrugs of deoxynucleosides for treatment of diseases cased by unbalanced nucleotide pools |
-
2022
- 2022-06-15 US US17/841,193 patent/US20230000890A1/en not_active Abandoned
- 2022-06-15 CA CA3222484A patent/CA3222484A1/en active Pending
- 2022-06-15 CN CN202280043337.3A patent/CN117500510A/zh active Pending
- 2022-06-15 MX MX2023014944A patent/MX2023014944A/es unknown
- 2022-06-15 JP JP2023577845A patent/JP2024522783A/ja active Pending
- 2022-06-15 AU AU2022291783A patent/AU2022291783A1/en active Pending
- 2022-06-15 EP EP22825758.0A patent/EP4355336A4/en active Pending
- 2022-06-15 IL IL309421A patent/IL309421A/en unknown
- 2022-06-15 WO PCT/US2022/033654 patent/WO2022266237A1/en not_active Ceased
-
2024
- 2024-07-12 US US18/771,259 patent/US20250049836A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014224111B2 (en) | Positively charged water-soluble prodrugs of 1H-imidazo[4,5-c]quinolin-4-amines and related compounds with very high skin penetration rates | |
| JP7559223B2 (ja) | リン脂質化合物及びその使用 | |
| JP6010196B2 (ja) | オキサゾリジノン含有二量体化合物、組成物、ならびに作製および使用方法 | |
| JP6087367B2 (ja) | 三環式化合物、それらを含む組成物およびそれらの使用 | |
| MX2014001549A (es) | Hemifumarato de tenofovir alafenamida. | |
| JP2004510698A5 (https=) | ||
| JP6261011B2 (ja) | 眼疾患処置薬 | |
| US9849143B2 (en) | Broad spectrum antiviral and methods of use | |
| US6489312B1 (en) | Pharmaceutical formulations comprising aminoalkyl phosphorothioates | |
| JPWO2015129809A1 (ja) | 虚血性眼疾患の処置用の医薬組成物 | |
| JP2021521210A5 (https=) | ||
| AU2015292050B2 (en) | New polycrystalline form of tenofovir prodrug, and preparation method and application therefor | |
| JP7830540B2 (ja) | ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス | |
| JP2024522783A5 (https=) | ||
| WO1990014007A1 (en) | Method for protection from azt side effects and toxicity | |
| KR20220115601A (ko) | 시스틴뇨증에 대한 시스틴 다이아미드 유사체 | |
| WO1989005637A1 (en) | Improving toxicity profiles in chemotherapy | |
| CN115400140A (zh) | 呋喃核糖基吡啶衍生物用于预防或治疗癫痫或惊厥的用途 | |
| CN111909204A (zh) | 一种替诺福韦双苯丙酸酯基氨基磷酸酯化合物及其药物组合物和用途 | |
| IL309421A (en) | Deoxynucleoside preparations for the treatment of mitochondrial diseases caused by unbalanced nucleotide pools | |
| CN111909205B (zh) | 一种替诺福韦双丙酸酯基氨基磷酸酯化合物及其药物组合物和用途 | |
| JP2016525546A (ja) | トリグリセリド、総コレステロール、及び低密度リポタンパク質の血中濃度を低減する方法 | |
| EA049672B1 (ru) | Фосфолипидные соединения и варианты их применения |